FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)

View source ↗

Summary

The FDA approved Waylis Therapeutics LLC's supplemental application for COREG CR, the extended-release formulation of carvedilol phosphate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Left Ventricular Dysfunction Following Myocardial Infarction

Drugs mentioned

• COREG CR (carvedilol phosphate)

Snippet

SUPPL AP for COREG CR (CARVEDILOL PHOSPHATE)